Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification-Reference-Cited by-同舟云学术

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification

Published:2019-11-19 Issue: Volume:10 Page:
ISSN:1664-8021
Container-title:Frontiers in Genetics
language:
Short-container-title:Front. Genet.

Author:

Walker Logan C.,Lattimore Vanessa Lilian,Kvist Anders,Kleiblova Petra,Zemankova Petra,de Jong Lucy,Wiggins George A. R.,Hakkaart Christopher,Cree Simone L.,Behar Raquel,Houdayer Claude,Investigators kConFab,Parsons Michael T.,Kennedy Martin A.,Spurdle Amanda B.,de la Hoya Miguel

Funder

Royal Society of New Zealand

National Health and Medical Research Council

Publisher

Frontiers Media SA

Subject

Genetics(clinical),Genetics,Molecular Medicine

Reference37 articles.

1. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion;Abou Tayoun;Hum. Mutat.,2018

2. Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity;Bosse;Cancer Res.,2012

3. Associations between cancer predisposition testing panel genes and breast cancer;Couch;JAMA Oncol.,2017

4. Detecting splicing patterns in genes involved in hereditary breast and ovarian cancer;Davy;Eur. J. Hum. Genet.,2017

5. Cancer predisposing missense and protein truncating BARD1 mutations in non-BRCA1 or BRCA2 breast cancer families;De Brakeleer;Hum. Mutat.,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Nanopore sequencing in precision cancer medicine;International Journal of Cancer;2024-07-19

2. A comprehensive analysis of germline predisposition to early-onset ovarian cancer;Scientific Reports;2024-07-13

3. A deep intronic recurrent CHEK2 variant c.1009-118_1009-87delinsC affects pre-mRNA splicing and contributes to hereditary breast cancer predisposition;The Breast;2024-06

4. Parallel DNA/RNA NGS Using an Identical Target Enrichment Panel in the Analysis of Hereditary Cancer Predisposition;Folia Biologica;2024

5. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup;The American Journal of Human Genetics;2023-07